Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Former FDA Commissioner Andrew von Eschenbach Joins Greenleaf Health as Senior Advisor
March 14th, 2009
Greenleaf Health LLC announced that Andrew C. von Eschenbach, MD, who recently stepped down as Commissioner of the Food and Drug Administration (FDA), has joined the firm as Senior Advisor. Greenleaf Health is a full service regulatory consulting firm that provides strategic guidance to companies regulated by the FDA and companies developing innovative solutions to pressing public health problems around the globe. Dr. von Eschenbach, who resigned as FDA Commissioner in January after leading the agency since 2005, will offer strategic counsel to Greenleaf's clients. Dr. von Eschenbach, an oncologist who previously served as director of the National Cancer Institute...
Source: Law & Health Weekly (2009-03-14)
|
